Ruju Wang
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Platelet Disorders and Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Peipei Xu (6 shared papers)Jian Ouyang (4 shared papers)Bing Chen (2 shared papers)Arsalan Ahmed (1 shared paper)Huaqin Zuo (1 shared paper)Yong Hu (1 shared paper)Jian Ouyang (1 shared paper)Xiaohui Wang (1 shared paper)
- Journals
- Chinese Physics Letters (6 papers)Blood (3 papers)Annals of Hematology (2 papers)Journal of Clinical Oncology (1 paper)Nanoscale Research Letters (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Ruju Wang
25 papers receiving 335 citations
Peers
Comparison fields: 5 of 77
- Biomaterials 81
- Hematology 46
- Oncology 64
- Ceramics and Composites 15
- Biomedical Engineering 104
Countries citing papers authored by Ruju Wang
This map shows the geographic impact of Ruju Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruju Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruju Wang more than expected).
Fields of papers citing papers by Ruju Wang
This network shows the impact of papers produced by Ruju Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruju Wang. The network helps show where Ruju Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruju Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 146 | |
| 2 | 2016 | 35 | |
| 3 | 2015 | 30 | |
| 4 | 2016 | 21 | |
| 5 | 2017 | 20 | |
| 6 | 2019 | 17 | |
| 7 | 2001 | 10 | |
| 8 | 2019 | 8 | |
| 9 | 2005 | 6 | |
| 10 | 1985 | 6 | |
| 11 | 1997 | 6 | |
| 12 | 2015 | 5 | |
| 13 | 2000 | 4 | |
| 14 | 2002 | 4 | |
| 15 | 2023 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 1993 | 2 | |
| 19 | 2002 | 2 | |
| 20 | 2021 | 2 |
About Ruju Wang
Ruju Wang is a scholar working on Materials Chemistry, Hematology, Molecular Biology, Oncology and Mechanical Engineering, having authored 27 papers that have together received 335 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Metallic Glasses and Amorphous Alloys (3 papers), CAR-T cell therapy research (3 papers), Superconductivity in MgB2 and Alloys (3 papers), Physics of Superconductivity and Magnetism (3 papers), Glass properties and applications (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Biomaterials (81 citations), Hematology (46 citations), Oncology (64 citations), Ceramics and Composites (15 citations) and Biomedical Engineering (104 citations). Ruju Wang has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Peipei Xu, Jian Ouyang, Bing Chen, Arsalan Ahmed, Huaqin Zuo, Yong Hu, Jian Ouyang, Bing Chen, Xiaohui Wang and Dan Sun. Their work appears in journals such as Chinese Physics Letters, Blood, Annals of Hematology, Journal of Clinical Oncology and Nanoscale Research Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.